Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline

Trial Profile

Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 16 Jan 2017

At a glance

  • Drugs Selegiline (Primary) ; Metamfetamine
  • Indications Alzheimer's disease; Attention-deficit hyperactivity disorder; Cognition disorders; Depression; Parkinson's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 06 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top